ir.en.immunicum.com ir.en.immunicum.com

ir.en.immunicum.com

Immunicum AB - Investors

Rights issue - read more. Download the memorandum. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Call for General Meetings. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact CEO Jamal El-Mosleh. Jamal El-Mosleh, CEO. E-post: jamal.el-mosleh@immunicum.com. View all ». Magnus Persson proposed new Board member of Immunicum.

http://ir.en.immunicum.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.EN.IMMUNICUM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 7 reviews
5 star
0
4 star
4
3 star
3
2 star
0
1 star
0

Hey there! Start your review of ir.en.immunicum.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.8 seconds

CONTACTS AT IR.EN.IMMUNICUM.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Immunicum AB - Investors | ir.en.immunicum.com Reviews
<META>
DESCRIPTION
Rights issue - read more. Download the memorandum. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Call for General Meetings. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact CEO Jamal El-Mosleh. Jamal El-Mosleh, CEO. E-post: jamal.el-mosleh@immunicum.com. View all ». Magnus Persson proposed new Board member of Immunicum.
<META>
KEYWORDS
1 choose language
2 immunicum
3 menu
4 sub menu
5 strategy
6 history
7 organization
8 board of directors
9 management
10 scientific advisory board
CONTENT
Page content here
KEYWORDS ON
PAGE
choose language,immunicum,menu,sub menu,strategy,history,organization,board of directors,management,scientific advisory board,technology,platforms,the combig platform,intuvax,subcuvax,the cd70 platform,intellectual property rights,scientific publications
SERVER
Microsoft-IIS/6.0
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Immunicum AB - Investors | ir.en.immunicum.com Reviews

https://ir.en.immunicum.com

Rights issue - read more. Download the memorandum. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Call for General Meetings. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact CEO Jamal El-Mosleh. Jamal El-Mosleh, CEO. E-post: jamal.el-mosleh@immunicum.com. View all ». Magnus Persson proposed new Board member of Immunicum.

OTHER SITES

ir.emc.com ir.emc.com

EMC Corporation - Home

Partner Code of Conduct. Powered By Q4 Web Systems.

ir.emergelp.com ir.emergelp.com

Investor Relations - Investor Relations Home | Emerge Energy Services

For additional information or materials, please contact ir@emergelp.com. Emerge Energy Services LP is a growth-oriented limited partnership engaged in the businesses of mining, producing, and distributing silica sand, a key input for the hydraulic fracturing of oil and natural gas wells. Emerge Energy also processes transmix, distributes refined motor fuels, operates bulk motor fuel . 160; 0.35. Data as of 08/14/15 4:02 pm ET. Minimum 20 minute delay. Click here for Information on K-1’s.

ir.emisphere.com ir.emisphere.com

Investor Relations - Emisphere Technologies, Inc.

Barriers to Oral Drug Delivery. Improved Oral Delivery with Eligen. About Eligen B12™. Eligen B12™ Information. 003 ( 8.31%). 12:28 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Feb 22, 2018. Aug 11, 2017. Emisphere Transitions to Non-Reporting Public Company. May 12, 2017 at 8:30 AM ET. Q1 2017 Financial Results Conference Call. Mar 29, 2017 at 8:30 AM ET. Q4 2016 and Full Year Financial Results Conference Call. 4 Becker Farm Road Suite 103 Roseland NJ 07068.

ir.emu.edu.tr ir.emu.edu.tr

Department of Political Science and International Relations | Faculty of Business and Economics, EMU

Department of Political Science and International Relations. Faculty of Business and Economics, EMU. Skip to primary content. Skip to secondary content. Assoc Prof. Dr. Erol Kaymak (Chair). Asst Prof. Dr. Umut Bozkurt (Vice-Chair). Prof Dr. Ahmet Sözen (Vice-Rector in Academic Affairs). Assoc Prof. Dr. Yücel Vural. Assoc Prof. Dr. Kudret Özersay. Assoc Prof. Dr. Wojciech Forysinski. Assist. Prof. Dr. Berna Numan (Academic Affairs Coordinator). Assist. Prof. Dr. Altay Nevzat. Dr Gülay Umaner Duba. Welcome...

ir.en.demasterblenders1753.com ir.en.demasterblenders1753.com

Investor Relations - Investor Relations - D.E MASTER BLENDERS 1753

Form 20-F/Annual Report 2012. Results Fiscal Year 2012. Interview Michiel Herkemij and Michel Cup. Changes to the Board of D.E MASTER BLENDERS 1753. Change in leadership at D.E MASTER BLENDERS 1753. Shareholders D.E MASTER BLENDERS 1753 vote in favor of all resolutions at the AGM. There are currently no events scheduled.

ir.en.immunicum.com ir.en.immunicum.com

Immunicum AB - Investors

Rights issue - read more. Download the memorandum. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Call for General Meetings. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact CEO Jamal El-Mosleh. Jamal El-Mosleh, CEO. E-post: jamal.el-mosleh@immunicum.com. View all ». Magnus Persson proposed new Board member of Immunicum.

ir.en.petrogrand.se ir.en.petrogrand.se

Investor Relations | Petrogrand AB

Jul 15, 2015. Production update for June 2015. Jun 23, 2015. Petrogrand AB resolutions of Annual General Meeting 2015. View all releases ». 46(0)8 - 5000 78 10.

ir.endurance.bm ir.endurance.bm

Endurance: Investor Relations

Skip to main content. Annual General Meeting Materials. Annual General Meeting Materials. 160; 0.09. August 03, 2015. Endurance Reports Second Quarter 2015 Financial Results. July 31, 2015. Endurance Announces Completion of Acquisition of Montpelier Re. July 30, 2015. Endurance Announces Receipt of All Regulatory Approvals for Acquisition of Montpelier Re. View all Press Releases. Tuesday, August 4, 2015 9:00 am ET. Q2 2015 Endurance Specialty Holdings Ltd. Earnings Conference Call.

ir.enea.pl ir.enea.pl

Relacje inwestorskie | Enea

Spółki Grupy Enea. Opłata zgodna z planem taryfowym). Konsultanci są dostępni od poniedziałku do piątku. W godz. 6.00-22.00 oraz. W soboty w godz. 8.00-16.00. Kontakt dla inwestorów. Opłata zgodna z planem taryfowym). Konsultanci są dostępni od poniedziałku do piątku. W godz. 6.00-22.00 oraz. W soboty w godz. 8.00-16.00. Kontakt dla mediów. Opłata zgodna z planem taryfowym). Konsultanci są dostępni od poniedziałku do piątku. W godz. 6.00-22.00 oraz. W soboty w godz. 8.00-16.00. Spółki Grupy Enea. Enea Op...

ir.enelandroid.com ir.enelandroid.com

Trucos Moviles con Android / iOS - Participa para Ganar un iPhone 7

Gana un iPhone 7! Haz Like en Nuestra Fanpage. Participa por tu iPhone 7. Descargar con MEGA Opción 1. Haz Me Gusta y Participa! Descargar con MEGA Opción 2. 2016 (c) Todos los trucos para tu Dispositivo Movil.

ir.ener-core.com ir.ener-core.com

Ener-Core, Inc. (ENCR)

Technology & Products. Power Oxidizer 250 KW. Power Oxidizer 333 KW. Power Oxidizer 2 MW. Operational & In Development Units. Sign up for email alerts. Be the first to receive breaking news. Ener-Core Receives $2.1 Million Purchase Order and Initial License Payment from Dresser-Rand. Aug 10, 2015. Ener-Core Power Oxidizer Successfully Passes Sub Scale Acceptance Test Milestone. Aug 3, 2015. Jun 30, 2015. Officers & Directors. Moscow Institute of Physics and Technology: Ph.D., Electrical Engineeri...North...